• Register
  • Login
  • Subscribe
  • Contact Us

Latest Medicinal Product Tenders in Czech 2026

CzechTenders brings you the latest and most relevant Medicinal Product tenders in Czech, sourced directly from reliable government portals, purchaser websites, and leading procurement publications. Whether you're a supplier, contractor, or manufacturer, we ensure you stay informed about ongoing bidding opportunities without missing a beat.

Our platform is regularly updated with tenders related to Medicinal Product and other keywords tenders. Each listing includes key details such as tender reference numbers, submission deadlines, and purchaser information helping you make informed bidding decisions quickly and confidently.

By subscribing to CzechTenders, users gain unlimited access to public procurement notices related to Medicinal Product. Our tools also offer category-based filtering, email alerts, and quick tender downloads, making your bidding process faster and more efficient. Stay ahead of the competition and grow your business by exploring verified tenders from both government and private entities across Czech.

Drug Supply - Active Substance Osimertinib - Atc L01eb04

CZT Ref No.:  114700939

Deadline:  19 Mar 2025

Drug Supply - the Active Substance Pembrolizumab - Atc L01ff02

CZT Ref No.:  114700547

Deadline:  17 Mar 2025

Radiofarmaka [2025-2027]

CZT Ref No.:  114699503

Deadline:  17 Mar 2025

Drug Supply - the Active Substance Fingolimod - Atc L04ae01

CZT Ref No.:  114698573

Deadline:  17 Mar 2025

Medicinal Products Containing Terlipressin and Somatropin

CZT Ref No.:  114696315

Deadline:  17 Mar 2025

Drug Supply - the Active Substance Fallen - Atc L04af03

CZT Ref No.:  114695533

Deadline:  19 Mar 2025

Medicinal Product with the Active Substance Infliximab Reopening

CZT Ref No.:  114566026

Deadline:  11 Mar 2025

Lp Containing Maribaviru 2025

CZT Ref No.:  114558667

Deadline:  17 Mar 2025

Medicinal Product with the Active Substance Pantoprazole

CZT Ref No.:  114553839

Deadline:  12 Mar 2025

  Chat with us